Catalyst Wire Dossier Catalyst Wire Dossier

DIGIBIND

digoxin immune Fab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DIGIBIND, covering 2012-05-25 to 2014-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Digibind for Treatment of Severe Preeclampsia [Phase 2]

See pricing